Paper23913792
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.
Eifert C and 6 others. Genes Chromosomes Cancer, 2013. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. Papers, record 23913792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23913792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Breast Neoplasms | Major topic |
| Protein-Tyrosine Kinases | Major topic |
| Agammaglobulinaemia Tyrosine Kinase | |
| Base Sequence | |
| Breast | |
| Cell Line | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Isoenzymes | |
| Molecular Sequence Data | |
| RNA Interference |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA136658 | NCI NIH HHS | United States | R01CA136658 | PubMed and NIH |
| R01CA136658 | NCI NIH HHS | United States | R01CA136658 | PubMed and NIH |
Source NIH RePORTER
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18982164 | Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18982164 | PubMed |
| 2 | 14570950 | Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. | JAMA | 2003 | https://conductscience.org/library/papers/14570950 | PubMed |
| 3 | 10344731 | Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3. | Cancer Res | 1999 | https://conductscience.org/library/papers/10344731 | PubMed |
| 4 | 21647634 | Monoclonal antibody to six transmembrane epithelial antigen of prostate-4 influences insulin sensitivity by attenuating phosphorylation of P13K (P85) and Akt: possible mitochondrial mechanism. | J Bioenerg Biomembr | 2011 | https://conductscience.org/library/papers/21647634 | PubMed |
| 5 | 18832579 | Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. | Am J Pathol | 2008 | https://conductscience.org/library/papers/18832579 | PubMed |
| 6 | 17096862 | HER2 therapy: molecular mechanisms of trastuzumab resistance. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/17096862 | PubMed |
| 7 | 21999571 | Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis. | BMC Genomics | 2011 | https://conductscience.org/library/papers/21999571 | PubMed |
| 8 | 15180538 | Therapeutic potential of inhibiting Bruton's tyrosine kinase, (BTK). | Curr Pharm Des | 2004 | https://conductscience.org/library/papers/15180538 | PubMed |
| 9 | 11146556 | The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. | Oncogene | 2000 | https://conductscience.org/library/papers/11146556 | PubMed |
| 10 | 12445832 | Phosphorylation of Bruton's tyrosine kinase by c-Abl. | Biochem Biophys Res Commun | 2002 | https://conductscience.org/library/papers/12445832 | PubMed |
| 11 | 16947082 | The role of the epidermal growth factor receptor in breast cancer. | J Mammary Gland Biol Neoplasia | 2006 | https://conductscience.org/library/papers/16947082 | PubMed |
| 12 | 7705943 | Expression of FGF and FGF receptor genes in human breast cancer. | Int J Cancer | 1995 | https://conductscience.org/library/papers/7705943 | PubMed |
| 13 | 16740702 | Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/16740702 | PubMed |
| 14 | 11875034 | Computational detection and location of transcription start sites in mammalian genomic DNA. | Genome Res | 2002 | https://conductscience.org/library/papers/11875034 | PubMed |
| 15 | 16166198 | Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. | FASEB J | 2005 | https://conductscience.org/library/papers/16166198 | PubMed |
| 16 | 19290921 | Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. | Immunol Rev | 2009 | https://conductscience.org/library/papers/19290921 | PubMed |
| 17 | 16200065 | Second-generation shRNA libraries covering the mouse and human genomes. | Nat Genet | 2005 | https://conductscience.org/library/papers/16200065 | PubMed |
| 18 | 15337524 | Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells. | Cell Signal | 2004 | https://conductscience.org/library/papers/15337524 | PubMed |
| 19 | 20096351 | Kinases as targets in the treatment of solid tumors. | Cell Signal | 2010 | https://conductscience.org/library/papers/20096351 | PubMed |
| 20 | 17249494 | RNAi applications in target validation. | Ernst Schering Res Found Workshop | 2007 | https://conductscience.org/library/papers/17249494 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902395 | Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypes. | Genome Biol | 2026 | https://conductscience.org/library/papers/42902395 | PubMed |
| 42827714 | Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42827714 | PubMed |
| 42071062 | Mutational profile of atypical fibroxanthoma and pleomorphic dermal sarcoma further expands the spectrum of genomic alterations in rare cutaneous neoplasms. | Sci Rep | 2026 | https://conductscience.org/library/papers/42071062 | PubMed |
| 41822319 | Expression of Bruton's Tyrosine Kinase Reflects Immune Cells Infiltration and Cell Proliferation in Breast Cancer. | World J Oncol | 2026 | https://conductscience.org/library/papers/41822319 | PubMed |
| 40445239 | Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/40445239 | PubMed |
| 39925800 | Case report: A panorama gene profile of ovarian cancer metastasized to axillary lymph node. | Front Immunol | 2025 | https://conductscience.org/library/papers/39925800 | PubMed |
| 39220827 | Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting. | 3 Biotech | 2024 | https://conductscience.org/library/papers/39220827 | PubMed |
| 38189455 | Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. | Elife | 2024 | https://conductscience.org/library/papers/38189455 | PubMed |
| 37738978 | Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37738978 | PubMed |
| 37685940 | Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial-Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC). | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37685940 | PubMed |
| 37638060 | Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells. | Anal Cell Pathol (Amst) | 2023 | https://conductscience.org/library/papers/37638060 | PubMed |
| 37070569 | Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/37070569 | PubMed |
| 36913160 | Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines. | Invest New Drugs | 2023 | https://conductscience.org/library/papers/36913160 | PubMed |
| 36903645 | Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. | Molecules | 2023 | https://conductscience.org/library/papers/36903645 | PubMed |
| 36612306 | BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36612306 | PubMed |
| 36139701 | Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139701 | PubMed |
| 35992808 | BTK, the new kid on the (oncology) block? | Front Oncol | 2022 | https://conductscience.org/library/papers/35992808 | PubMed |
| 35935048 | Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach. | Adv Pharm Bull | 2022 | https://conductscience.org/library/papers/35935048 | PubMed |
| 35873012 | Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer Cells. | Iran J Pharm Res | 2022 | https://conductscience.org/library/papers/35873012 | PubMed |
| 35732327 | Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling. | Cancer Genomics Proteomics | 2022 | https://conductscience.org/library/papers/35732327 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23913792
GET https://conductscience.org/api/papers/v1/23913792/references?page=2